![The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today](http://evtoday.com/images/articles/2019-10/1019_Supp8_Fig5.png)
The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today
![The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today](http://evtoday.com/images/articles/2019-10/1019_Supp8_Fig1.png)
The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today
![The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X17300716-gr1.jpg)
The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect
![The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X17300716-gr4.jpg)
The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect
![CRT-300.08 Single-Center Study Evaluating Long-Term Major Adverse Outcomes With the Use of the Lutonix Drug-Coated Balloon in Treating Infrainguinal Arterial Disease | JACC: Cardiovascular Interventions CRT-300.08 Single-Center Study Evaluating Long-Term Major Adverse Outcomes With the Use of the Lutonix Drug-Coated Balloon in Treating Infrainguinal Arterial Disease | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/7b2abdd6-770f-4b84-be25-af727dcb277f/j.jcin.2022.01.164.fp.png)
CRT-300.08 Single-Center Study Evaluating Long-Term Major Adverse Outcomes With the Use of the Lutonix Drug-Coated Balloon in Treating Infrainguinal Arterial Disease | JACC: Cardiovascular Interventions
![Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study) | Circulation Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study) | Circulation](https://www.ahajournals.org/cms/asset/eab136d7-7933-4f97-9a96-8934c4e68b88/circulationaha.122.059646.fig01.jpg)
Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study) | Circulation
![Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine - ScienceDirect Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1051044316303384-gr1.jpg)